Skip to main content
Clinical Trials/ACTRN12622001338752
ACTRN12622001338752Not yet recruiting未知

The effectiveness of airway clearance in bronchiectasis: A prospective cohort study and review of the patient experience

The University of Sydney0 sites86 target enrollmentStarted: October 18, 2022Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Enrollment
86

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 Years to o limit (—)
Sex
All

Inclusion Criteria

  • 1)Provide their informed consent to participate.
  • 2)Male or Female above 18 years of age (inclusive) at screening.
  • 3)Bronchiectasis diagnosed by a treating physician.

Exclusion Criteria

  • 1)Current smokers as defined by the Centre of Disease C ontrol.
  • 2)Inability to follow the procedures of the study (e.g. due to barriers of language or cognition)
  • 3)Cardiothoracic surgery within 6 weeks prior to enrolment
  • 4)Subjects who have had adjustments to their baseline medications within 1 month prior to screening
  • 5)Subjects who started on macrolides within 12 months of enrolment.
  • 6)Subjects taking antibiotics for an acute exacerbation at the time of enrolment.
  • 7)Severe concomitant illness that may prevent optimal participation in the study
  • 8)A direct relative of the investigation team
  • 9)Women who are pregnant
  • 10)Participation in another clinical trial for bronchiectasis

Investigators

Similar Trials